Evaluation of Efficacy and Safety of Rituximab and Mycophenolate Mofetil Combination in Patients With Interstitial Lung Disease Related to Systemic Sclerosis
Clinical trial NCT06549231 · RECRUITING
Trial details
- NCT number
- NCT06549231
- Sponsor
- University Hospital, Tours
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-08
- Primary completion
- 2028-07-08
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.